Mirum Pharmaceuticals Raises FY2026 Sales Guidance from $630.000M-$650.000M to $660.000M-$680.000M vs $644.905M Est

Benzinga Newsdesk www.benzinga.com Positive 94.4%

Neg 0% Neu 0% Pos 94.4%

Mirum Pharmaceuticals (NASDAQ:MIRM) raises FY2026 sales outlook from $630.000 million-$650.000 million to $660.000 million-$680.000 million vs $644.905 million estimate.